Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer
- PMID: 27738342
- PMCID: PMC5355350
- DOI: 10.18632/oncotarget.12563
Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer
Abstract
Background and aim: High levels of peripheral plasma fibrinogen have recently been revealed that related to poor clinical prognosis in various types of malignant tumors. The purpose of this research was to identify the prognostic significance of the preoperative peripheral serum fibrinogen level in patients with penile cell carcinoma.
Methods: This retrospective research included 72 penile cancer patients with date about their serum fibrinogen value before surgery who undergone either partial or radical penectomy at The 2nd Hospital of Tianjin Medical University between January 2002 to January 2012. They had a mean follow-up of 30.8 months. To determine the factors that were significant in predicting a patient's prognosis, univariate and multivariate analyses were performed according to the Cox proportional hazards regression model.
Results: The 5-year cancer specific survival (CSS) rate was 62.4% of patients with preoperative fibrinogen levels below 340 mg/dl and 41.9% for those with higher levels (p = 0.001). Multivariate analysis revealed that the pathological T stage (p < 0.001), tumor grade (p = 0.036), postoperative chemotherapy (p = 0.041), nodal metastasis(p < 0.001), pathological type (p < 0.001) and fibrinogen (p = 0.023) were independent prognostic factors for survival. Patients with low fibrinogen level (<340mg/dl) had significantly longer CSS and the different survival rate were defined using the log-rank test.
Conclusions: The high preoperative peripheral serum fibrinogen level was related to poor survival in penile cancer patients. Fibrinogen may serve as a powerful predictor of CSS in penile cancer patients.
Keywords: biomarker; fibrinogen; penile cancer; prognosis; survival.
Conflict of interest statement
All the authors declare they have no competing of interest.
Figures







References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. - PubMed
-
- Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, Watkin NA, European Association of Urology Guidelines Group on Penile C. EAU penile cancer guidelines 2009 Eur Urol. 2010;57:1002–1012. - PubMed
-
- Novara G, Galfano A, De Marco V, Artibani W, Ficarra V. Prognostic factors in squamous cell carcinoma of the penis. Nature Clinical Practice Urology. 2007;4:140–146. - PubMed
-
- Hungerhuber E, Schlenker B, Schneede P, Stief CG, Karl A. Squamous cell carcinoma antigen correlates with tumor burden but lacks prognostic potential for occult lymph node metastases in penile cancer. Urology. 2007;70:975–979. - PubMed
-
- Ficarra V, Akduman B, Bouchot O, Palou J, Tobias-Machado M. Prognostic Factors in Penile Cancer. Urology. 2010;76:S66–S73. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources